The Wnt signaling pathway and its role in tumor development
10.1007/s00432-003-0431-0
Crossref journal-article
Springer Science and Business Media LLC
Journal of Cancer Research and Clinical Oncology (297)
Bibliography

Lustig, B., & Behrens, J. (2003). The Wnt signaling pathway and its role in tumor development. Journal of Cancer Research and Clinical Oncology, 129(4), 199–221.

Authors 2
  1. B. Lustig (first)
  2. J. Behrens (additional)
References 257 Referenced 390
  1. Abraham SC, Montgomery EA, Giardiello FM, Wu TT (2001a) Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas. Am J Pathol 158:1073–1078 (10.1016/S0002-9440(10)64054-0) / Am J Pathol by Abraham (2001)
  2. Abraham SC, Wu TT, Klimstra DS, Finn LS, Lee JH, Yeo CJ, Cameron JL, Hruban RH (2001b) Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: frequent alterations in the APC/beta-catenin pathway and chromosome 11p. Am J Pathol 159:1619–1627 (10.1016/S0002-9440(10)63008-8) / Am J Pathol by Abraham (2001)
  3. Abraham SC, Klimstra DS, Wilentz RE, Yeo CJ, Conlon K, Brennan M, Cameron JL, Wu TT, Hruban RH (2002a) Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol 160:1361–1369 (10.1016/S0002-9440(10)62563-1) / Am J Pathol by Abraham (2002)
  4. Abraham SC, Wu TT, Hruban RH, Lee JH, Yeo CJ, Conlon K, Brennan M, Cameron JL, Klimstra DS (2002b) Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol 160:953–962 (10.1016/S0002-9440(10)64917-6) / Am J Pathol by Abraham (2002)
  5. Albuquerque C, Breukel C, van der Luijt R, Fidalgo P, Lage P, Slors FJ, Leitao CN, Fodde R, Smits R (2002) The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum Mol Genet 11:1549–1560 (10.1093/hmg/11.13.1549) / Hum Mol Genet by Albuquerque (2002)
  6. Amit S, Hatzubai A, Birman Y, Andersen JS, Ben-Shushan E, Mann M, Ben-Neriah Y, Alkalay I (2002) Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev 16:1066–1076 (10.1101/gad.230302) / Genes Dev by Amit (2002)
  7. Aoki M, Hecht A, Kruse U, Kemler R, Vogt PK (1999) Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1. Proc Natl Acad Sci U S A 96:139–144 (10.1073/pnas.96.1.139) / Proc Natl Acad Sci U S A by Aoki (1999)
  8. Baeza N, Masuoka J, Kleihues P, Ohgaki H (2003) AXIN1 mutations but not deletions in cerebellar medulloblastomas. Oncogene 22:632–636 (10.1038/sj.onc.1206156) / Oncogene by Baeza (2003)
  9. Barker N, Hurlstone A, Musisi H, Miles A, Bienz M, Clevers H (2001) The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation. Embo J 20:4935–4943 (10.1093/emboj/20.17.4935) / Embo J by Barker (2001)
  10. Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G, Meeldijk J, Robertson J, van de Wetering M, Pawson T, Clevers H (2002) Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111:251–263 (10.1016/S0092-8674(02)01015-2) / Cell by Batlle (2002)
  11. Bauer A, Chauvet S, Huber O, Usseglio F, Rothbacher U, Aragnol D, Kemler R, Pradel J (2000) Pontin52 and reptin52 function as antagonistic regulators of beta-catenin signalling activity. Embo J 19:6121–6130 (10.1093/emboj/19.22.6121) / Embo J by Bauer (2000)
  12. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382:638–642 (10.1038/382638a0) / Nature by Behrens (1996)
  13. Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, Wirtz R, Kuhl M, Wedlich D, Birchmeier W (1998) Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280:596–599 (10.1126/science.280.5363.596) / Science by Behrens (1998)
  14. Bhanot P, Brink M, Samos CH, Hsieh JC, Wang Y, Macke JP, Andrew D, Nathans J, Nusse R (1996) A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382:225–230 (10.1038/382225a0) / Nature by Bhanot (1996)
  15. Bienz M, Clevers H (2000) Linking colorectal cancer to Wnt signaling. Cell 103:311–320 (10.1016/S0092-8674(00)00122-7) / Cell by Bienz (2000)
  16. Bienz M (2001) Spindles cotton on to junctions, APC and EB1. Nat Cell Biol 3:E67–68 (10.1038/35060140) / Nat Cell Biol by Bienz (2001)
  17. Bienz M (2002) The subcellular destinations of APC proteins. Nat Rev Mol Cell Biol 3:328–338 (10.1038/nrm806) / Nat Rev Mol Cell Biol by Bienz (2002)
  18. Boon EM, van der Neut R, van de Wetering M, Clevers H, Pals ST (2002) Wnt signaling regulates expression of the receptor tyrosine kinase met in colorectal cancer. Cancer Res 62:5126–5128 / Cancer Res by Boon (2002)
  19. Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T (1999) Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155:1033–1038 (10.1016/S0002-9440(10)65204-2) / Am J Pathol by Brabletz (1999)
  20. Brabletz T, Jung A, Kirchner T (2002) Beta-catenin and the morphogenesis of colorectal cancer. Virchows Arch 441:1–11 (10.1007/s00428-002-0642-9) / Virchows Arch by Brabletz (2002)
  21. Cadigan KM, Nusse R (1997) Wnt signaling: a common theme in animal development. Genes Dev 11:3286–3305 (10.1101/gad.11.24.3286) / Genes Dev by Cadigan (1997)
  22. Camp RL, Chung GG, Rimm DL (2002) Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 8:1323–1327 (10.1038/nm791) / Nat Med by Camp (2002)
  23. Capelluto DG, Kutateladze TG, Habas R, Finkielstein CV, He X, Overduin M (2002) The DIX domain targets dishevelled to actin stress fibres and vesicular membranes. Nature 419:726–729 (10.1038/nature01056) / Nature by Capelluto (2002)
  24. Cetta F, Montalto G, Gori M, Curia MC, Cama A, Olschwang S (2000) Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab 85:286–292 / J Clin Endocrinol Metab by Cetta (2000)
  25. Chan EF, Gat U, McNiff JM, Fuchs E (1999) A common human skin tumour is caused by activating mutations in beta-catenin. Nat Genet 21:410–413 (10.1038/7747) / Nat Genet by Chan (1999)
  26. Chan SK, Struhl G (2002) Evidence that Armadillo transduces wingless by mediating nuclear export or cytosolic activation of Pangolin. Cell 111:265–280 (10.1016/S0092-8674(02)01037-1) / Cell by Chan (2002)
  27. Cheadle JP, Krawczak M, Thomas MW, Hodges AK, Al-Tassan N, Fleming N, Sampson JR (2002) Different combinations of biallelic APC mutation confer different growth advantages in colorectal tumours. Cancer Res 62:363–366 / Cancer Res by Cheadle (2002)
  28. Cheon SS, Cheah AY, Turley S, Nadesan P, Poon R, Clevers H, Alman BA (2002) Beta-catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc Natl Acad Sci USA 99:6973–6978 (10.1073/pnas.102657399) / Proc Natl Acad Sci USA by Cheon (2002)
  29. Chesire DR, Ewing CM, Sauvageot J, Bova GS, Isaacs WB (2000) Detection and analysis of beta-catenin mutations in prostate cancer. Prostate 45:323–334 (10.1002/1097-0045(20001201)45:4<323::AID-PROS7>3.0.CO;2-W) / Prostate by Chesire (2000)
  30. Chesire DR, Isaacs WB (2002) Ligand-dependent inhibition of beta-catenin/TCF signaling by androgen receptor. T cell factor. Oncogene 21:8453–8469 (10.1038/sj.onc.1206049) / Oncogene by Chesire (2002)
  31. Cheyette BN, Waxman JS, Miller JR, Takemaru K, Sheldahl LC, Khlebtsova N, Fox EP, Earnest T, Moon RT (2002) Dapper, a Dishevelled-associated antagonist of beta-catenin and JNK signaling, is required for notochord formation. Dev Cell 2:449–461 (10.1016/S1534-5807(02)00140-5) / Dev Cell by Cheyette (2002)
  32. Choi YW, Heath EI, Heitmiller R, Forastiere AA, Wu TT (2000) Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas. Mod Pathol 13:1055–1059 (10.1038/modpathol.3880194) / Mod Pathol by Choi (2000)
  33. Chung EJ, Hwang SG, Nguyen P, Lee S, Kim JS, Kim JW, Henkart PA, Bottaro DP, Soon L, Bonvini P, Lee SJ, Karp JE, Oh HJ, Rubin JS, Trepel JB (2002) Regulation of leukemic cell adhesion, proliferation, and survival by beta-catenin. Blood 100:982–990 (10.1182/blood.V100.3.982) / Blood by Chung (2002)
  34. Chung GG, Provost E, Kielhorn EP, Charette LA, Smith BL, Rimm DL (2001) Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis. Clin Cancer Res 7:4013–4020 / Clin Cancer Res by Chung (2001)
  35. Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio-Preiser C, Groden J, Lowy AM (2002) Beta-catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 62:3503–3506 / Cancer Res by Clements (2002)
  36. Clevers H (2002) Inflating cell numbers by wnt. Mol Cell 10:1260–1261 (10.1016/S1097-2765(02)00801-8) / Mol Cell by Clevers (2002)
  37. Conacci-Sorrell ME, Ben-Yedidia T, Shtutman M, Feinstein E, Einat P, Ben-Ze'ev A (2002) Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. Genes Dev 16:2058–2072 (10.1101/gad.227502) / Genes Dev by Conacci-Sorrell (2002)
  38. Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, Polakis P, Matrisian LM (1999) The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 18:2883–2891 (10.1038/sj.onc.1202627) / Oncogene by Crawford (1999)
  39. Dahmen RP, Koch A, Denkhaus D, Tonn JC, Sorensen N, Berthold F, Behrens J, Birchmeier W, Wiestler OD, Pietsch T (2001) Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res 61:7039–7043 / Cancer Res by Dahmen (2001)
  40. Damalas A, Ben-Ze'ev A, Simcha I, Shtutman M, Leal JF, Zhurinsky J, Geiger B, Oren M (1999) Excess beta-catenin promotes accumulation of transcriptionally active p53. Embo J 18:3054–3063 (10.1093/emboj/18.11.3054) / Embo J by Damalas (1999)
  41. De Filippo C, Luceri C, Caderni G, Pacini M, Messerini L, Biggeri A, Mini E, Tonelli F, Cianchi F, Dolara P (2002) Mutations of the APC gene in human sporadic colorectal cancers. Scand J Gastroenterol 37:1048–1053 (10.1080/003655202320378248) / Scand J Gastroenterol by De (2002)
  42. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C (1998) Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95:8847–8851 (10.1073/pnas.95.15.8847) / Proc Natl Acad Sci USA by de (1998)
  43. Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Gonzalez S, Tarafa G, Sidransky D, Meltzer SJ, Baylin SB, Herman JG (2000) Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 60:4366–4371 / Cancer Res by Esteller (2000)
  44. Farr GH 3rd, Ferkey DM, Yost C, Pierce SB, Weaver C, Kimelman D (2000) Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification. J Cell Biol 148:691–702 (10.1083/jcb.148.4.691) / J Cell Biol by Farr (2000)
  45. Fearnhead NS, Britton MP, Bodmer WF (2001) The ABC of APC. Hum Mol Genet 10:721–733 (10.1093/hmg/10.7.721) / Hum Mol Genet by Fearnhead (2001)
  46. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767 (10.1016/0092-8674(90)90186-I) / Cell by Fearon (1990)
  47. Fodde R, Edelmann W, Yang K, van Leeuwen C, Carlson C, Renault B, Breukel C, Alt E, Lipkin M, Khan PM, et al (1994) A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci USA 91:8969–8973 (10.1073/pnas.91.19.8969) / Proc Natl Acad Sci USA by Fodde (1994)
  48. Fodde R, Kuipers J, Rosenberg C, Smits R, Kielman M, Gaspar C, van Es JH, Breukel C, Wiegant J, Giles RH, Clevers H (2001) Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 3:433–438 (10.1038/35070129) / Nat Cell Biol by Fodde (2001)
  49. Friedl W, Caspari R, Sengteller M, Uhlhaas S, Lamberti C, Jungck M, Kadmon M, Wolf M, Fahnenstich J, Gebert J, Moslein G, Mangold E, Propping P (2001) Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut 48:515–521 (10.1136/gut.48.4.515) / Gut by Friedl (2001)
  50. Fujimori M, Ikeda S, Shimizu Y, Okajima M, Asahara T (2001) Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor. Cancer Res 61:6656–6659 / Cancer Res by Fujimori (2001)
  51. Galceran J, Farinas I, Depew MJ, Clevers H, Grosschedl R (1999) Wnt3a-/--like phenotype and limb deficiency in Lef1(-/-)Tcf1(-/-) mice. Genes Dev 13:709–717 (10.1101/gad.13.6.709) / Genes Dev by Galceran (1999)
  52. Gamallo C, Palacios J, Moreno G, Calvo de Mora J, Suarez A, Armas A (1999) beta-catenin expression pattern in stage I and II ovarian carcinomas: relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome. Am J Pathol 155:527–536 (10.1016/S0002-9440(10)65148-6) / Am J Pathol by Gamallo (1999)
  53. Garcia-Rostan G, Tallini G, Herrero A, D'Aquila TG, Carcangiu ML, Rimm DL (1999) Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. Cancer Res 59:1811–1815 / Cancer Res by Garcia-Rostan (1999)
  54. Garcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL, Tallini G (2001) Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. Am J Pathol 158:987–996 (10.1016/S0002-9440(10)64045-X) / Am J Pathol by Garcia-Rostan (2001)
  55. Gat U, DasGupta R, Degenstein L, Fuchs E (1998) De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell 95:605–614 (10.1016/S0092-8674(00)81631-1) / Cell by Gat (1998)
  56. Gayet J, Zhou XP, Duval A, Rolland S, Hoang JM, Cottu P, Hamelin R (2001) Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. Oncogene 20:5025–5032 (10.1038/sj.onc.1204611) / Oncogene by Gayet (2001)
  57. Gerdes B, Ramaswamy A, Simon B, Pietsch T, Bastian D, Kersting M, Moll R, Bartsch D (1999) Analysis of beta-catenin gene mutations in pancreatic tumors. Digestion 60:544–548 (10.1159/000007704) / Digestion by Gerdes (1999)
  58. Gerstein AV, Almeida TA, Zhao G, Chess E, Shih Ie M, Buhler K, Pienta K, Rubin MA, Vessella R, Papadopoulos N (2002) APC/CTNNB1 (beta-catenin) pathway alterations in human prostate cancers. Genes Chromosomes Cancer 34:9–16 (10.1002/gcc.10037) / Genes Chromosomes Cancer by Gerstein (2002)
  59. Giese K, Kingsley C, Kirshner JR, Grosschedl R (1995) Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev 9:995–1008 (10.1101/gad.9.8.995) / Genes Dev by Giese (1995)
  60. Gloy J, Hikasa H, Sokol SY (2002) Frodo interacts with Dishevelled to transduce Wnt signals. Nat Cell Biol 4:351–357 (10.1038/ncb784) / Nat Cell Biol by Gloy (2002)
  61. Gounari F, Signoretti S, Bronson R, Klein L, Sellers WR, Kum J, Siermann A, Taketo MM, von Boehmer H, Khazaie K (2002) Stabilization of beta-catenin induces lesions reminiscent of prostatic intraepithelial neoplasia, but terminal squamous transdifferentiation of other secretory epithelia. Oncogene 21:4099–4107 (10.1038/sj.onc.1205562) / Oncogene by Gounari (2002)
  62. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, et al (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589–600 (10.1016/0092-8674(81)90021-0) / Cell by Groden (1991)
  63. Groves C, Lamlum H, Crabtree M, Williamson J, Taylor C, Bass S, Cuthbert-Heavens D, Hodgson S, Phillips R, Tomlinson I (2002) Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis. Am J Pathol 160:2055–2061 (10.1016/S0002-9440(10)61155-8) / Am J Pathol by Groves (2002)
  64. Gunther K, Brabletz T, Kraus C, Dworak O, Reymond MA, Jung A, Hohenberger W, Kirchner T, Kockerling F, Ballhausen WG (1998) Predictive value of nuclear beta-catenin expression for the occurrence of distant metastases in rectal cancer. Dis Colon Rectum 41:1256–1261 (10.1007/BF02258226) / Dis Colon Rectum by Gunther (1998)
  65. Gupta RA, Dubois RN (2001) Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1:11–21 (10.1038/35094017) / Nat Rev Cancer by Gupta (2001)
  66. Habas R, Kato Y, He X (2001) Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein Daam1. Cell 107:843–854 (10.1016/S0092-8674(01)00614-6) / Cell by Habas (2001)
  67. Hamada F, Bienz M (2002) A Drosophila APC tumour suppressor homologue functions in cellular adhesion. Nat Cell Biol 4:208–213 (10.1038/ncb755) / Nat Cell Biol by Hamada (2002)
  68. Hamamoto T, Beppu H, Okada H, Kawabata M, Kitamura T, Miyazono K, Kato M (2002) Compound disruption of smad2 accelerates malignant progression of intestinal tumors in apc knockout mice. Cancer Res 62:5955–5961 / Cancer Res by Hamamoto (2002)
  69. Hamblet NS, Lijam N, Ruiz-Lozano P, Wang J, Yang Y, Luo Z, Mei L, Chien KR, Sussman DJ, Wynshaw-Boris A (2002) Dishevelled 2 is essential for cardiac outflow tract development, somite segmentation and neural tube closure. Development 129:5827–5838 (10.1242/dev.00164) / Development by Hamblet (2002)
  70. Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, Taketo MM (1999) Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. Embo J 18:5931–5942 (10.1093/emboj/18.21.5931) / Embo J by Harada (1999)
  71. Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P (1998) Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol 8:573–581 (10.1016/S0960-9822(98)70226-X) / Curr Biol by Hart (1998)
  72. Haydon RC, Deyrup A, Ishikawa A, Heck R, Jiang W, Zhou L, Feng T, King D, Cheng H, Breyer B, Peabody T, Simon MA, Montag AG, He TC (2002) Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma. Int J Cancer 102:338–342 (10.1002/ijc.10719) / Int J Cancer by Haydon (2002)
  73. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509–1512 (10.1126/science.281.5382.1509) / Science by He (1998)
  74. Hecht A, Vleminckx K, Stemmler MP, van Roy F, Kemler R (2000) The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates. Embo J 19:1839–1850 (10.1093/emboj/19.8.1839) / Embo J by Hecht (2000)
  75. Heisenberg CP (2002) Wnt signalling: refocusing on Strabismus. Curr Biol 12:R657–659 (10.1016/S0960-9822(02)01160-0) / Curr Biol by Heisenberg (2002)
  76. Henderson BR, Fagotto F (2002) The ins and outs of APC and beta-catenin nuclear transport. EMBO Rep 3:834–839 (10.1093/embo-reports/kvf181) / EMBO Rep by Henderson (2002)
  77. Hernegger GS, Moore HG, Guillem JG (2002) Attenuated familial adenomatous polyposis: an evolving and poorly understood entity. Dis Colon Rectum 45:127–134 (10.1007/s10350-004-6127-y) / Dis Colon Rectum by Hernegger (2002)
  78. Hiltunen MO, Alhonen L, Koistinaho J, Myohanen S, Paakkonen M, Marin S, Kosma VM, Janne J (1997) Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. Int J Cancer 70:644–648 (10.1002/(SICI)1097-0215(19970317)70:6<644::AID-IJC3>3.0.CO;2-V) / Int J Cancer by Hiltunen (1997)
  79. Hlubek F, Jung A, Kotzor N, Kirchner T, Brabletz T (2001) Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin. Cancer Res 61:8089–8093 / Cancer Res by Hlubek (2001)
  80. Hommura F, Furuuchi K, Yamazaki K, Ogura S, Kinoshita I, Shimizu M, Moriuchi T, Katoh H, Nishimura M, Dosaka-Akita H (2002) Increased expression of beta-catenin predicts better prognosis in nonsmall cell lung carcinomas. Cancer 94:752–758 (10.1002/cncr.10213) / Cancer by Hommura (2002)
  81. Hoshida Y, Hongyo T, Nakatsuka S, Nishiu M, Takakuwa T, Tomita Y, Nomura T, Aozasa K (2002) Gene mutations in lymphoproliferative disorders of T and NK/T cell phenotypes developing in renal transplant patients. Lab Invest 82:257–264 (10.1038/labinvest.3780419) / Lab Invest by Hoshida (2002)
  82. Hovanes K, Li TW, Munguia JE, Truong T, Milovanovic T, Lawrence Marsh J, Holcombe RF, Waterman ML (2001) Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet 28:53–57 (10.1038/88264) / Nat Genet by Hovanes (2001)
  83. Howe LR, Subbaramaiah K, Chung WJ, Dannenberg AJ, Brown AM (1999) Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res 59:1572–1577 / Cancer Res by Howe (1999)
  84. Howe LR, Crawford HC, Subbaramaiah K, Hassell JA, Dannenberg AJ, Brown AM (2001) PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2. J Biol Chem 276:20108–20115 (10.1074/jbc.M010692200) / J Biol Chem by Howe (2001)
  85. Hsu SC, Galceran J, Grosschedl R (1998) Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin. Mol Cell Biol 18:4807–4818 (10.1128/MCB.18.8.4807) / Mol Cell Biol by Hsu (1998)
  86. Hsu W, Shakya R, Costantini F (2001) Impaired mammary gland and lymphoid development caused by inducible expression of Axin in transgenic mice. J Cell Biol 155:1055–1064 (10.1083/jcb.200107066) / J Cell Biol by Hsu (2001)
  87. Huang H, Fujii H, Sankila A, Mahler-Araujo BM, Matsuda M, Cathomas G, Ohgaki H (1999) Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am J Pathol 155:1795–1801 (10.1016/S0002-9440(10)65496-X) / Am J Pathol by Huang (1999)
  88. Huang H, Mahler-Araujo BM, Sankila A, Chimelli L, Yonekawa Y, Kleihues P, Ohgaki H (2000) APC mutations in sporadic medulloblastomas. Am J Pathol 156:433–437 (10.1016/S0002-9440(10)64747-5) / Am J Pathol by Huang (2000)
  89. Huber AH, Weis WI (2001) The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell 105:391–402 (10.1016/S0092-8674(01)00330-0) / Cell by Huber (2001)
  90. Huelsken J, Vogel R, Erdmann B, Cotsarelis G, Birchmeier W (2001) Beta-catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 105:533–545 (10.1016/S0092-8674(01)00336-1) / Cell by Huelsken (2001)
  91. Hulsken J, Birchmeier W, Behrens J (1994) E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol 127:2061–2069 (10.1083/jcb.127.6.2061) / J Cell Biol by Hulsken (1994)
  92. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A (1998) Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. Embo J 17:1371–1384 (10.1093/emboj/17.5.1371) / Embo J by Ikeda (1998)
  93. Ikeda S, Kishida M, Matsuura Y, Usui H, Kikuchi A (2000) GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin. Oncogene 19:537–545 (10.1038/sj.onc.1203359) / Oncogene by Ikeda (2000)
  94. Ilyas M, Tomlinson IP, Rowan A, Pignatelli M, Bodmer WF (1997) Beta-catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci USA 94:10330–10334 (10.1073/pnas.94.19.10330) / Proc Natl Acad Sci USA by Ilyas (1997)
  95. Imbert A, Eelkema R, Jordan S, Feiner H, Cowin P (2001) Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J Cell Biol 153:555–568 (10.1083/jcb.153.3.555) / J Cell Biol by Imbert (2001)
  96. Inomata M, Ochiai A, Akimoto S, Kitano S, Hirohashi S (1996) Alteration of beta-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Cancer Res 56:2213–2217 / Cancer Res by Inomata (1996)
  97. Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F (2002) Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22:1172–1183 (10.1128/MCB.22.4.1172-1183.2002) / Mol Cell Biol by Jho (2002)
  98. Jimbo T, Kawasaki Y, Koyama R, Sato R, Takada S, Haraguchi K, Akiyama T (2002) Identification of a link between the tumour suppressor APC and the kinesin superfamily. Nat Cell Biol 4:323–327 (10.1038/ncb779) / Nat Cell Biol by Jimbo (2002)
  99. Jonkers J, Korswagen HC, Acton D, Breuer M, Berns A (1997) Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas. Embo J 16:441–450 (10.1093/emboj/16.3.441) / Embo J by Jonkers (1997)
  100. Kang DE, Soriano S, Xia X, Eberhart CG, De Strooper B, Zheng H, Koo EH (2002) Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis. Cell 110:751–762 (10.1016/S0092-8674(02)00970-4) / Cell by Kang (2002)
  101. Kaplan KB, Burds AA, Swedlow JR, Bekir SS, Sorger PK, Nathke IS (2001) A role for the adenomatous polyposis coli protein in chromosome segregation. Nat Cell Biol 3:429–432 (10.1038/35070123) / Nat Cell Biol by Kaplan (2001)
  102. Kawakami M, Kimura Y, Furuhata T, Zenbutsu H, Yanai Y, Mukaiya M, Satoh Y, Murata S, Hirata K (2002) Beta-catenin alteration in cancer of the ampulla of Vater. J Exp Clin Cancer Res 21:23–27 / J Exp Clin Cancer Res by Kawakami (2002)
  103. Kawasaki Y, Senda T, Ishidate T, Koyama R, Morishita T, Iwayama Y, Higuchi O, Akiyama T (2000) Asef, a link between the tumor suppressor APC and G-protein signaling. Science 289:1194–1197 (10.1126/science.289.5482.1194) / Science by Kawasaki (2000)
  104. Kerr NJ, Fukuzawa R, Reeve AE, Sullivan MJ, Fukazawa R (2002) Beckwith-Wiedemann syndrome, pancreatoblastoma, and the wnt signaling pathway. Am J Pathol 160:1541–1542 (10.1016/S0002-9440(10)62580-1) / Am J Pathol by Kerr (2002)
  105. Kielhorn E, Provost E, Olsen D, D'Aquila TG, Smith BL, Camp RL, Rimm DL (2003) Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome. Int J Cancer 103:652–656 (10.1002/ijc.10893) / Int J Cancer by Kielhorn (2003)
  106. Kielman MF, Rindapaa M, Gaspar C, van Poppel N, Breukel C, van Leeuwen S, Taketo MM, Roberts S, Smits R, Fodde R (2002) Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Nat Genet 32:594–605 (10.1038/ng1045) / Nat Genet by Kielman (2002)
  107. Kim JS, Crooks H, Dracheva T, Nishanian TG, Singh B, Jen J, Waldman T (2002) Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. Cancer Res 62:2744–2748 / Cancer Res by Kim (2002)
  108. Kim K, Pang KM, Evans M, Hay ED (2000) Overexpression of beta-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators. Mol Biol Cell 11:3509–3523 (10.1091/mbc.11.10.3509) / Mol Biol Cell by Kim (2000)
  109. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D, et al (1991) Identification of FAP locus genes from chromosome 5q21. Science 253:661–665 (10.1126/science.1651562) / Science by Kinzler (1991)
  110. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87:159–170 (10.1016/S0092-8674(00)81333-1) / Cell by Kinzler (1996)
  111. Kishida S, Yamamoto H, Ikeda S, Kishida M, Sakamoto I, Koyama S, Kikuchi A (1998) Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin. J Biol Chem 273:10823–10826 (10.1074/jbc.273.18.10823) / J Biol Chem by Kishida (1998)
  112. Kitaeva MN, Grogan L, Williams JP, Dimond E, Nakahara K, Hausner P, DeNobile JW, Soballe PW, Kirsch IR (1997) Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. Cancer Res 57:4478–4481 / Cancer Res by Kitaeva (1997)
  113. Kitagawa M, Hatakeyama S, Shirane M, Matsumoto M, Ishida N, Hattori K, Nakamichi I, Kikuchi A, Nakayama K (1999) An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. Embo J 18:2401–2410 (10.1093/emboj/18.9.2401) / Embo J by Kitagawa (1999)
  114. Koch A, Denkhaus D, Albrecht S, Leuschner I, von Schweinitz D, Pietsch T (1999) Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Cancer Res 59:269–273 / Cancer Res by Koch (1999)
  115. Koch A, Waha A, Tonn JC, Sorensen N, Berthold F, Wolter M, Reifenberger J, Hartmann W, Friedl W, Reifenberger G, Wiestler OD, Pietsch T (2001) Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors. Int J Cancer 93:445–449 (10.1002/ijc.1342) / Int J Cancer by Koch (2001)
  116. Koesters R, Ridder R, Kopp-Schneider A, Betts D, Adams V, Niggli F, Briner J von Knebel, Doeberitz M (1999) Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors. Cancer Res 59:3880–3882 / Cancer Res by Koesters (1999)
  117. Koh TJ, Bulitta CJ, Fleming JV, Dockray GJ, Varro A, Wang TC (2000) Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis. J Clin Invest 106:533–539 (10.1172/JCI9476) / J Clin Invest by Koh (2000)
  118. Kolligs FT, Nieman MT, Winer I, Hu G, Van Mater D, Feng Y, Smith IM, Wu R, Zhai Y, Cho KR, Fearon ER (2002) ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation. Cancer Cell 1:145–155 (10.1016/S1535-6108(02)00035-1) / Cancer Cell by Kolligs (2002)
  119. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275:1784–1787 (10.1126/science.275.5307.1784) / Science by Korinek (1997)
  120. Kramps T, Peter O, Brunner E, Nellen D, Froesch B, Chatterjee S, Murone M, Zullig S, Basler K (2002) Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell 109:47–60 (10.1016/S0092-8674(02)00679-7) / Cell by Kramps (2002)
  121. Kratochwil K, Dull M, Farinas I, Galceran J, Grosschedl R (1996) Lef1 expression is activated by BMP-4 and regulates inductive tissue interactions in tooth and hair development. Genes Dev 10:1382–1394 (10.1101/gad.10.11.1382) / Genes Dev by Kratochwil (1996)
  122. Kuhnen C, Herter P, Muller O, Muehlberger T, Krause L, Homann H, Steinau HU, Muller KM (2000) Beta-catenin in soft tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas. Mod Pathol 13:1005–1013 (10.1038/modpathol.3880181) / Mod Pathol by Kuhnen (2000)
  123. Kusafuka T, Miao J, Kuroda S, Udatsu Y, Yoneda A (2002) Codon 45 of the beta-catenin gene, a specific mutational target site of Wilms' tumor. Int J Mol Med 10:395–399 / Int J Mol Med by Kusafuka (2002)
  124. Lamlum H, Ilyas M, Rowan A, Clark S, Johnson V, Bell J, Frayling I, Efstathiou J, Pack K, Payne S, Roylance R, Gorman P, Sheer D, Neale K, Phillips R, Talbot I, Bodmer W, Tomlinson I (1999) The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat Med 5:1071–1075 (10.1038/12511) / Nat Med by Lamlum (1999)
  125. Lamlum H, Al Tassan N, Jaeger E, Frayling I, Sieber O, Reza FB, Eckert M, Rowan A, Barclay E, Atkin W, Williams C, Gilbert J, Cheadle J, Bell J, Houlston R, Bodmer W, Sampson J, Tomlinson I (2000) Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. Hum Mol Genet 9:2215–2221 (10.1093/oxfordjournals.hmg.a018912) / Hum Mol Genet by Lamlum (2000)
  126. Lee JH, Abraham SC, Kim HS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Rashid A, Hamilton SR, Wu TT (2002) Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am J Pathol 161:611–618 (10.1016/S0002-9440(10)64216-2) / Am J Pathol by Lee (2002)
  127. Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick R, Hanash S, Cho KR, Fearon ER (2002) Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. J Biol Chem 277:21657–21665 (10.1074/jbc.M200139200) / J Biol Chem by Leung (2002)
  128. Li C, Bapat B, Alman BA (1998) Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor). Am J Pathol 153:709–714 (10.1016/S0002-9440(10)65614-3) / Am J Pathol by Li (1998)
  129. Li L, Yuan H, Weaver CD, Mao J, Farr GH 3rd, Sussman DJ, Jonkers J, Kimelman D, Wu D (1999) Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. Embo J 18:4233–4240 (10.1093/emboj/18.15.4233) / Embo J by Li (1999)
  130. Lijam N, Paylor R, McDonald MP, Crawley JN, Deng CX, Herrup K, Stevens KE, Maccaferri G, McBain CJ, Sussman DJ, Wynshaw-Boris A (1997) Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell 90:895–905 (10.1016/S0092-8674(00)80354-2) / Cell by Lijam (1997)
  131. Lin YM, Ono K, Satoh S, Ishiguro H, Fujita M, Miwa N, Tanaka T, Tsunoda T, Yang KC, Nakamura Y, Furukawa Y (2001) Identification of AF17 as a downstream gene of the beta-catenin/T-cell factor pathway and its involvement in colorectal carcinogenesis. Cancer Res 61:6345–6349 / Cancer Res by Lin (2001)
  132. Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X (2002) Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108:837–847 (10.1016/S0092-8674(02)00685-2) / Cell by Liu (2002)
  133. Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL, White RL, Matsunami N (2001a) Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell 7:927–936 (10.1016/S1097-2765(01)00241-6) / Mol Cell by Liu (2001)
  134. Liu T, DeCostanzo AJ, Liu X, Wang H, Hallagan S, Moon RT, Malbon CC (2001b) G protein signaling from activated rat frizzled-1 to the beta-catenin-Lef-Tcf pathway. Science 292:1718–1722 (10.1126/science.1060100) / Science by Liu (2001)
  135. Liu W, Dong X, Mai M, Seelan RS, Taniguchi K, Krishnadath KK, Halling KC, Cunningham JM, Boardman LA, Qian C, Christensen E, Schmidt SS, Roche PC, Smith DI, Thibodeau SN (2000) Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet 26:146–147 (10.1038/79859) / Nat Genet by Liu (2000)
  136. Lockhart-Mummery A (1925) Cancer and Heredity. Lancet 1:427–429 (10.1016/S0140-6736(00)95996-8) / Lancet by Lockhart-Mummery (1925)
  137. Lovig T, Meling GI, Diep CB, Thorstensen L, Norheim Andersen S, Lothe RA, Rognum TO (2002) APC and CTNNB1 mutations in a large series of sporadic colorectal carcinomas stratified by the microsatellite instability status. Scand J Gastroenterol 37:1184–1193 (10.1080/003655202760373407) / Scand J Gastroenterol by Lovig (2002)
  138. Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, Karsten U, van de Wetering M, Clevers H, Schlag PM, Birchmeier W, Behrens J (2002) Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol 22:1184–1193 (10.1128/MCB.22.4.1184-1193.2002) / Mol Cell Biol by Lustig (2002)
  139. Maiti S, Alam R, Amos CI, Huff V (2000) Frequent association of beta-catenin and WT1 mutations in Wilms tumors. Cancer Res 60:6288–6292 / Cancer Res by Maiti (2000)
  140. Malbon CC, Wang H, Moon RT (2001) Wnt signaling and heterotrimeric G-proteins: strange bedfellows or a classic romance? Biochem Biophys Res Commun 287:589–593 (10.1006/bbrc.2001.5630) / Biochem Biophys Res Commun by Malbon (2001)
  141. Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A, Niehrs C (2001a) LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411:321–325 (10.1038/35077108) / Nature by Mao (2001)
  142. Mao J, Wang J, Liu B, Pan W, Farr GH 3rd, Flynn C, Yuan H, Takada S, Kimelman D, Li L, Wu D (2001b) Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol Cell 7:801–809 (10.1016/S1097-2765(01)00224-6) / Mol Cell by Mao (2001)
  143. Mao B, Wu W, Davidson G, Marhold J, Li M, Mechler BM, Delius H, Hoppe D, Stannek P, Walter C, Glinka A, Niehrs C (2002) Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 417:664–667 (10.1038/nature756) / Nature by Mao (2002)
  144. Marchenko GN, Marchenko ND, Leng J, Strongin AY (2002) Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin. Biochem J 363:253–262 (10.1042/0264-6021:3630253) / Biochem J by Marchenko (2002)
  145. Martin B, Schneider R, Janetzky S, Waibler Z, Pandur P, Kuhl M, Behrens J, von der Mark K, Starzinski-Powitz A, Wixler V (2002) The LIM-only protein FHL2 interacts with beta-catenin and promotes differentiation of mouse myoblasts. J Cell Biol 159:113–122 (10.1083/jcb.200202075) / J Cell Biol by Martin (2002)
  146. Matsumine A, Ogai A, Senda T, Okumura N, Satoh K, Baeg GH, Kawahara T, Kobayashi S, Okada M, Toyoshima K, Akiyama T (1996) Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein. Science 272:1020–1023 (10.1126/science.272.5264.1020) / Science by Matsumine (1996)
  147. Matsuzawa SI, Reed JC (2001) Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell 7:915–926 (10.1016/S1097-2765(01)00242-8) / Mol Cell by Matsuzawa (2001)
  148. McCrea PD, Turck CW, Gumbiner B (1991) A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin. Science 254:1359–1361 (10.1126/science.1962194) / Science by McCrea (1991)
  149. Miller JR (2002) The Wnts. Genome Biol 3[Review]:S3001
  150. Mimori-Kiyosue Y, Shiina N, Tsukita S (2000) The dynamic behavior of the APC-binding protein EB1 on the distal ends of microtubules. Curr Biol 10:865–868 (10.1016/S0960-9822(00)00600-X) / Curr Biol by Mimori-Kiyosue (2000)
  151. Mirabelli-Primdahl L, Gryfe R, Kim H, Millar A, Luceri C, Dale D, Holowaty E, Bapat B, Gallinger S, Redston M (1999) Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res 59:3346–3351 / Cancer Res by Mirabelli-Primdahl (1999)
  152. Miyaki M, Iijima T, Kimura J, Yasuno M, Mori T, Hayashi Y, Koike M, Shitara N, Iwama T, Kuroki T (1999) Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res 59:4506–4509 / Cancer Res by Miyaki (1999)
  153. Miyoshi Y, Iwao K, Nawa G, Yoshikawa H, Ochi T, Nakamura Y (1998) Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Oncol Res 10:591–594 / Oncol Res by Miyoshi (1998)
  154. Mogensen MM, Tucker JB, Mackie JB, Prescott AR, Nathke IS (2002) The adenomatous polyposis coli protein unambiguously localizes to microtubule plus ends and is involved in establishing parallel arrays of microtubule bundles in highly polarized epithelial cells. J Cell Biol 157:1041–1048 (10.1083/jcb.200203001) / J Cell Biol by Mogensen (2002)
  155. Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V, Roose J, Destree O, Clevers H (1996) XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86:391–399 (10.1016/S0092-8674(00)80112-9) / Cell by Molenaar (1996)
  156. Moreno-Bueno G, Hardisson D, Sanchez C, Sarrio D, Cassia R, Garcia-Rostan G, Prat J, Guo M, Herman JG, Matias-Guiu X, Esteller M, Palacios J (2002) Abnormalities of the APC/beta-catenin pathway in endometrial cancer. Oncogene 21:7981–7990 (10.1038/sj.onc.1205924) / Oncogene by Moreno-Bueno (2002)
  157. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787–1790 (10.1126/science.275.5307.1787) / Science by Morin (1997)
  158. Mukhopadhyay M, Shtrom S, Rodriguez-Esteban C, Chen L, Tsukui T, Gomer L, Dorward DW, Glinka A, Grinberg A, Huang SP, Niehrs C, Belmonte JC, Westphal H (2001) Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse. Dev Cell 1:423–434 (10.1016/S1534-5807(01)00041-7) / Dev Cell by Mukhopadhyay (2001)
  159. Mulholland DJ, Cheng H, Reid K, Rennie PS, Nelson CC (2002) The androgen receptor can promote beta-catenin nuclear translocation independently of adenomatous polyposis coli. J Biol Chem 277:17933–17943 (10.1074/jbc.M200135200) / J Biol Chem by Mulholland (2002)
  160. Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P (1995) Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 92:3046–3050 (10.1073/pnas.92.7.3046) / Proc Natl Acad Sci USA by Munemitsu (1995)
  161. Nakamura M, Zhou XZ, Lu KP (2001) Critical role for the EB1 and APC interaction in the regulation of microtubule polymerization. Curr Biol 11:1062–1067 (10.1016/S0960-9822(01)00297-4) / Curr Biol by Nakamura (2001)
  162. Nathke IS, Adams CL, Polakis P, Sellin JH, Nelson WJ (1996) The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration. J Cell Biol 134:165–179 (10.1083/jcb.134.1.165) / J Cell Biol by Nathke (1996)
  163. Niemann C, Owens DM, Hulsken J, Birchmeier W, Watt FM (2002) Expression of DeltaNLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours. Development 129:95–109 (10.1242/dev.129.1.95) / Development by Niemann (2002)
  164. Omholt K, Platz A, Ringborg U, Hansson J (2001) Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma. Int J Cancer 92:839–842 (10.1002/ijc.1270) / Int J Cancer by Omholt (2001)
  165. Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M (1995) Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci USA 92:4482–4486 (10.1073/pnas.92.10.4482) / Proc Natl Acad Sci USA by Oshima (1995)
  166. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87:803–809 (10.1016/S0092-8674(00)81988-1) / Cell by Oshima (1996)
  167. Ougolkov AV, Yamashita K, Mai M, Minamoto T (2002) Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer. Gastroenterology 122:60–71 (10.1053/gast.2002.30306) / Gastroenterology by Ougolkov (2002)
  168. Park WS, Oh RR, Park JY, Lee SH, Shin MS, Kim YS, Kim SY, Lee HK, Kim PJ, Oh ST, Yoo NJ, Lee JY (1999) Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. Cancer Res 59:4257–4260 / Cancer Res by Park (1999)
  169. Park WS, Oh RR, Park JY, Kim PJ, Shin MS, Lee JH, Kim HS, Lee SH, Kim SY, Park YG, An WG, Jang JJ, Yoo NJ, Lee JY (2001) Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma. J Pathol 193:483–490 (10.1002/1096-9896(2000)9999:9999<::AID-PATH804>3.0.CO;2-R) / J Pathol by Park (2001)
  170. Peifer M (1993) Cancer, catenins, and cuticle pattern: a complex connection. Science 262:1667–1668 (10.1126/science.8259511) / Science by Peifer (1993)
  171. Peifer M, Berg S, Reynolds AB (1994) A repeating amino acid motif shared by proteins with diverse cellular roles. Cell 76:789–791 (10.1016/0092-8674(94)90353-0) / Cell by Peifer (1994)
  172. Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J, Brush J, Taneyhill LA, Deuel B, Lew M, Watanabe C, Cohen RL, Melhem MF, Finley GG, Quirke P, Goddard AD, Hillan KJ, Gurney AL, Botstein D, Levine AJ (1998) WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA 95:14717–14722 (10.1073/pnas.95.25.14717) / Proc Natl Acad Sci USA by Pennica (1998)
  173. Polakis P (2000) Wnt signaling and cancer. Genes Dev 14:1837–1851 (10.1101/gad.14.15.1837) / Genes Dev by Polakis (2000)
  174. Pollock PM, Hayward N (2002) Mutations in exon 3 of the beta-catenin gene are rare in melanoma cell lines. Melanoma Res 12:183–186 (10.1097/00008390-200204000-00013) / Melanoma Res by Pollock (2002)
  175. Ransohoff DF (2002) Fecal DNA tests for colorectal cancer. N Engl J Med 346:1912–1913 (10.1056/NEJM200206133462414) / N Engl J Med by Ransohoff (2002)
  176. Reifenberger J, Knobbe CB, Wolter M, Blaschke B, Schulte KW, Pietsch T, Ruzicka T, Reifenberger G (2002) Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC. Int J Cancer 100:549–556 (10.1002/ijc.10512) / Int J Cancer by Reifenberger (2002)
  177. Rimm DL, Caca K, Hu G, Harrison FB, Fearon ER (1999) Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma. Am J Pathol 154:325–329 (10.1016/S0002-9440(10)65278-9) / Am J Pathol by Rimm (1999)
  178. Rockman SP, Currie SA, Ciavarella M, Vincan E, Dow C, Thomas RJ, Phillips WA (2001) Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma. J Biol Chem 276:45113–45119 (10.1074/jbc.M107742200) / J Biol Chem by Rockman (2001)
  179. Romagnolo B, Berrebi D, Saadi-Keddoucci S, Porteu A, Pichard AL, Peuchmaur M, Vandewalle A, Kahn A, Perret C (1999) Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin. Cancer Res 59:3875–3879 / Cancer Res by Romagnolo (1999)
  180. Roose J, Molenaar M, Peterson J, Hurenkamp J, Brantjes H, Moerer P, van de Wetering M, Destree O, Clevers H (1998) The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors. Nature 395:608–612 (10.1038/26989) / Nature by Roose (1998)
  181. Roose J, Clevers H (1999) TCF transcription factors: molecular switches in carcinogenesis. Biochim Biophys Acta 1424:M23–37 (10.1016/S0304-419X(99)00026-8) / Biochim Biophys Acta by Roose (1999)
  182. Roose J, Huls G, van Beest M, Moerer P, van der Horn K, Goldschmeding R, Logtenberg T, Clevers H (1999) Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science 285:1923–1926 (10.1126/science.285.5435.1923) / Science by Roose (1999)
  183. Rosin-Arbesfeld R, Ihrke G, Bienz M (2001) Actin-dependent membrane association of the APC tumour suppressor in polarized mammalian epithelial cells. Embo J 20:5929–5939 (10.1093/emboj/20.21.5929) / Embo J by Rosin-Arbesfeld (2001)
  184. Rousset R, Mack JA, Wharton KA Jr, Axelrod JD, Cadigan KM, Fish MP, Nusse R, Scott MP (2001) Naked cuticle targets dishevelled to antagonize Wnt signal transduction. Genes Dev 15:658–6571 (10.1101/gad.869201) / Genes Dev by Rousset (2001)
  185. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P (1996) Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272:1023–1026 (10.1126/science.272.5264.1023) / Science by Rubinfeld (1996)
  186. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P (1997) Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 275:1790–1792 (10.1126/science.275.5307.1790) / Science by Rubinfeld (1997)
  187. Rubinfeld B, Tice DA, Polakis P (2001) Axin-dependent phosphorylation of the adenomatous polyposis coli protein mediated by casein kinase 1epsilon. J Biol Chem 276:39037–39045 (10.1074/jbc.M105148200) / J Biol Chem by Rubinfeld (2001)
  188. Ruckert S, Hiendlmeyer E, Brueckl WM, Oswald U, Beyser K, Dietmaier W, Haynl A, Koch C, Ruschoff J, Brabletz T, Kirchner T, Jung A (2002) T-cell factor-4 frameshift mutations occur frequently in human microsatellite instability-high colorectal carcinomas but do not contribute to carcinogenesis. Cancer Res 62:3009–3013 / Cancer Res by Ruckert (2002)
  189. Sadot E, Geiger B, Oren M, Ben-Ze'ev A (2001) Down-regulation of beta-catenin by activated p53. Mol Cell Biol 21:6768–6781 (10.1128/MCB.21.20.6768-6781.2001) / Mol Cell Biol by Sadot (2001)
  190. Sakamoto A, Oda Y, Adachi T, Saito T, Tamiya S, Iwamoto Y, Tsuneyoshi M (2002) Beta-catenin accumulation and gene mutation in exon 3 in dedifferentiated liposarcoma and malignant fibrous histiocytoma. Arch Pathol Lab Med 126:1071–1078 (10.5858/2002-126-1071-CAAGMI) / Arch Pathol Lab Med by Sakamoto (2002)
  191. Sakanaka C, Weiss JB, Williams LT (1998) Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription. Proc Natl Acad Sci USA 95:3020–3023 (10.1073/pnas.95.6.3020) / Proc Natl Acad Sci USA by Sakanaka (1998)
  192. Salic A, Lee E, Mayer L, Kirschner MW (2000) Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. Mol Cell 5:523–532 (10.1016/S1097-2765(00)80446-3) / Mol Cell by Salic (2000)
  193. Sarris A, Ford R (1999) Recent advances in the molecular pathogenesis of lymphomas. Curr Opin Oncol 11:351–363 (10.1097/00001622-199909000-00006) / Curr Opin Oncol by Sarris (1999)
  194. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y (2000) AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24:245–250 (10.1038/73448) / Nat Genet by Satoh (2000)
  195. Schwarz-Romond T, Asbrand C, Bakkers J, Kuhl M, Schaeffer HJ, Huelsken J, Behrens J, Hammerschmidt M, Birchmeier W (2002) The ankyrin repeat protein Diversin recruits Casein kinase Iepsilon to the beta-catenin degradation complex and acts in both canonical Wnt and Wnt/JNK signaling. Genes Dev 16:2073–2084 (10.1101/gad.230402) / Genes Dev by Schwarz-Romond (2002)
  196. Seeling JM, Miller JR, Gil R, Moon RT, White R, Virshup DM (1999) Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A. Science 283:2089–2091 (10.1126/science.283.5410.2089) / Science by Seeling (1999)
  197. Sekine S, Shibata T, Kokubu A, Morishita Y, Noguchi M, Nakanishi Y, Sakamoto M, Hirohashi S (2002) Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol 161:1997–2001 (10.1016/S0002-9440(10)64477-X) / Am J Pathol by Sekine (2002)
  198. Shibata H, Toyama K, Shioya H, Ito M, Hirota M, Hasegawa S, Matsumoto H, Takano H, Akiyama T, Toyoshima K, Kanamaru R, Kanegae Y, Saito I, Nakamura Y, Shiba K, Noda T (1997) Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 278:120–123 (10.1126/science.278.5335.120) / Science by Shibata (1997)
  199. Shih IM, Wang TL, Traverso G, Romans K, Hamilton SR, Ben-Sasson S, Kinzler KW, Vogelstein B (2001) Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci USA 98:2640–2645 (10.1073/pnas.051629398) / Proc Natl Acad Sci USA by Shih (2001)
  200. Shou J, Ali-Osman F, Multani AS, Pathak S, Fedi P, Srivenugopal KS (2002) Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA. Oncogene 21:878–889 (10.1038/sj.onc.1205138) / Oncogene by Shou (2002)
  201. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A (1999) The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96:5522–5527 (10.1073/pnas.96.10.5522) / Proc Natl Acad Sci USA by Shtutman (1999)
  202. Shtutman M, Zhurinsky J, Oren M, Levina E, Ben-Ze'ev A (2002) PML is a target gene of beta-catenin and plakoglobin, and coactivates beta-catenin-mediated transcription. Cancer Res 62:5947–5954 / Cancer Res by Shtutman (2002)
  203. Sieber OM, Heinimann K, Gorman P, Lamlum H, Crabtree M, Simpson CA, Davies D, Neale K, Hodgson SV, Roylance RR, Phillips RK, Bodmer WF, Tomlinson IP (2002) Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC. Proc Natl Acad Sci USA 99:16910–16915 (10.1073/pnas.012679099) / Proc Natl Acad Sci USA by Sieber (2002)
  204. Smits R, Kielman MF, Breukel C, Zurcher C, Neufeld K, Jagmohan-Changur S, Hofland N, van Dijk J, White R, Edelmann W, Kucherlapati R, Khan PM, Fodde R (1999) Apc1638T: a mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development. Genes Dev 13:1309–1321 (10.1101/gad.13.10.1309) / Genes Dev by Smits (1999)
  205. Sokol SY (1999) Wnt signaling and dorso-ventral axis specification in vertebrates. Curr Opin Genet Dev 9:405–410 (10.1016/S0959-437X(99)80061-6) / Curr Opin Genet Dev by Sokol (1999)
  206. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW (1998) Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58:1130–1134 / Cancer Res by Sparks (1998)
  207. Spiegelman VS, Slaga TJ, Pagano M, Minamoto T, Ronai Z, Fuchs SY (2000) Wnt/beta-catenin signaling induces the expression and activity of betaTrCP ubiquitin ligase receptor. Mol Cell 5:877–882 (10.1016/S1097-2765(00)80327-5) / Mol Cell by Spiegelman (2000)
  208. Staal FJ, Noort Mv M, Strous GJ, Clevers HC (2002) Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO Rep 3:63–68 (10.1093/embo-reports/kvf002) / EMBO Rep by Staal (2002)
  209. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946–1952 (10.1056/NEJM200006293422603) / N Engl J Med by Steinbach (2000)
  210. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA, Dove WF (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256:668–670 (10.1126/science.1350108) / Science by Su (1992)
  211. Su LK, Vogelstein B, Kinzler KW (1993) Association of the APC tumor suppressor protein with catenins. Science 262:1734–1737 (10.1126/science.8259519) / Science by Su (1993)
  212. Su LK, Burrell M, Hill DE, Gyuris J, Brent R, Wiltshire R, Trent J, Vogelstein B, Kinzler KW (1995) APC binds to the novel protein EB1. Cancer Res 55:2972–2977 / Cancer Res by Su (1995)
  213. Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, Fantl WJ, Williams LT (2001) PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling. Nat Cell Biol 3:628–636 (10.1038/35083016) / Nat Cell Biol by Sun (2001)
  214. Takahashi M, Fujita M, Furukawa Y, Hamamoto R, Shimokawa T, Miwa N, Ogawa M, Nakamura Y (2002) Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis. Cancer Res 62:5651–5656 / Cancer Res by Takahashi (2002)
  215. Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Taketo MM (1998) Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92:645–656 (10.1016/S0092-8674(00)81132-0) / Cell by Takaku (1998)
  216. Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y, Hess F, Saint-Jeannet JP, He X (2000) LDL-receptor-related proteins in Wnt signal transduction. Nature 407:530–535 (10.1038/35035117) / Nature by Tamai (2000)
  217. Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W (2002) Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 21:4863–4871 (10.1038/sj.onc.1205591) / Oncogene by Taniguchi (2002)
  218. Tejpar S, Nollet F, Li C, Wunder JS, Michils G, dal Cin P, Van Cutsem E, Bapat B, van Roy F, Cassiman JJ, Alman BA (1999) Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18:6615–6620 (10.1038/sj.onc.1203041) / Oncogene by Tejpar (1999)
  219. Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422–426 (10.1038/18884) / Nature by Tetsu (1999)
  220. Thompson B, Townsley F, Rosin-Arbesfeld R, Musisi H, Bienz M (2002) A new nuclear component of the Wnt signalling pathway. Nat Cell Biol 4:367–373 (10.1038/ncb786) / Nat Cell Biol by Thompson (2002)
  221. Traverso G, Shuber A, Levin B, Johnson C, Olsson L, Schoetz DJ Jr, Hamilton SR, Boynton K, Kinzler KW, Vogelstein B (2002) Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 346:311–320 (10.1056/NEJMoa012294) / N Engl J Med by Traverso (2002)
  222. Truica CI, Byers S, Gelmann EP (2000) Beta-catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res 60:4709–4713 / Cancer Res by Truica (2000)
  223. van de Wetering M, Cavallo R, Dooijes D, van Beest M, van Es J, Loureiro J, Ypma A, Hursh D, Jones T, Bejsovec A, Peifer M, Mortin M, Clevers H (1997) Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88:789–799 (10.1016/S0092-8674(00)81925-X) / Cell by van (1997)
  224. van de Wetering M, de Lau W, Clevers H (2002a) WNT signaling and lymphocyte development. Cell 109 Suppl:S13–19 / Cell 109 by van (2002)
  225. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, van den Born M, Soete G, Pals S, Eilers M, Medema R, Clevers H (2002b) The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111:241–250 (10.1016/S0092-8674(02)01014-0) / Cell by van (2002)
  226. van Noort M, Clevers H (2002) TCF transcription factors, mediators of Wnt-signaling in development and cancer. Dev Biol 244:1–248 (10.1006/dbio.2001.0566) / Dev Biol by van (2002)
  227. van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H (2002) Wnt signaling controls the phosphorylation status of beta-catenin. J Biol Chem 277:17901–17905 (10.1074/jbc.M111635200) / J Biol Chem by van (2002)
  228. Verbeek S, Izon D, Hofhuis F, Robanus-Maandag E, te Riele H, van de Wetering M, Oosterwegel M, Wilson A, MacDonald HR, Clevers H (1995) An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature 374:70–74 (10.1038/374070a0) / Nature by Verbeek (1995)
  229. Vleminckx K, Kemler R, Hecht A (1999) The C-terminal transactivation domain of beta-catenin is necessary and sufficient for signaling by the LEF-1/beta-catenin complex in Xenopus laevis. Mech Dev 81:65–74 (10.1016/S0925-4773(98)00225-1) / Mech Dev by Vleminckx (1999)
  230. Voeller HJ, Truica CI, Gelmann EP (1998) Beta-catenin mutations in human prostate cancer. Cancer Res 58:2520–2523 / Cancer Res by Voeller (1998)
  231. von Kries JP, Winbeck G, Asbrand C, Schwarz-Romond T, Sochnikova N, Dell'Oro A, Behrens J, Birchmeier W (2000) Hot spots in beta-catenin for interactions with LEF-1, conductin and APC. Nat Struct Biol 7:800–807 (10.1038/79039) / Nat Struct Biol by von (2000)
  232. Wakefield JG, Stephens DJ, Tavare JM (2003) A role for glycogen synthase kinase-3 in mitotic spindle dynamics and chromosome alignment. J Cell Sci 116:637–646 (10.1242/jcs.00273) / J Cell Sci by Wakefield (2003)
  233. Watson SA, Smith AM (2001) Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis. Cancer Res 61:625–631 / Cancer Res by Watson (2001)
  234. Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, Trent JM (2002) Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1:279–288 (10.1016/S1535-6108(02)00045-4) / Cancer Cell by Weeraratna (2002)
  235. Wehrli M, Dougan ST, Caldwell K, O'Keefe L, Schwartz S, Vaizel-Ohayon D, Schejter E, Tomlinson A, DiNardo S (2000) arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 407:527–530 (10.1038/35035110) / Nature by Wehrli (2000)
  236. Wharton KA Jr (2003) Runnin' with the Dvl: proteins that associate with Dsh/Dvl and their significance to Wnt signal transduction. Dev Biol 253:1–17 (10.1006/dbio.2002.0869) / Dev Biol by Wharton (2003)
  237. Widlund HR, Horstmann MA, Price ER, Cui J, Lessnick SL, Wu M, He X, Fisher DE (2002) Beta-catenin-induced melanoma growth requires the downstream target microphthalmia-associated transcription factor. J Cell Biol 158:1079–1087 (10.1083/jcb.200202049) / J Cell Biol by Widlund (2002)
  238. Wiechens N, Fagotto F (2001) CRM1- and Ran-independent nuclear export of beta-catenin. Curr Biol 11:18–27 (10.1016/S0960-9822(00)00045-2) / Curr Biol by Wiechens (2001)
  239. Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R, Clevers H, Pals ST (1999) Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 154:515–523 (10.1016/S0002-9440(10)65297-2) / Am J Pathol by Wielenga (1999)
  240. Wilding J, Straub J, Bee J, Churchman M, Bodmer W, Dickson C, Tomlinson I, Ilyas M (2002) Cyclin D1 is not an essential target of beta-catenin signaling during intestinal tumorigenesis, but it may act as a modifier of disease severity in multiple intestinal neoplasia (Min) mice. Cancer Res 62:4562–4565 / Cancer Res by Wilding (2002)
  241. Willert J, Epping M, Pollack JR, Brown PO, Nusse R (2002) A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol 2:8 (10.1186/1471-213X-2-8) / BMC Dev Biol by Willert (2002)
  242. Willert K, Brink M, Wodarz A, Varmus H, Nusse R (1997) Casein kinase 2 associates with and phosphorylates dishevelled. Embo J 16:3089–3096 (10.1093/emboj/16.11.3089) / Embo J by Willert (1997)
  243. Willert K, Shibamoto S, Nusse R (1999) Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex. Genes Dev 13:1768–1773 (10.1101/gad.13.14.1768) / Genes Dev by Willert (1999)
  244. Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ, Harper JW (1999) The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev 13:270–283 (10.1101/gad.13.21.2751) / Genes Dev by Winston (1999)
  245. Wolf D, Rodova M, Miska EA, Calvet JP, Kouzarides T (2002) Acetylation of beta-catenin by CREB-binding protein (CBP). J Biol Chem 277:25562–25567 (10.1074/jbc.M201196200) / J Biol Chem by Wolf (2002)
  246. Wu R, Zhai Y, Fearon ER, Cho KR (2001) Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res 61:8247–8255 / Cancer Res by Wu (2001)
  247. Xu L, Corcoran RB, Welsh JW, Pennica D, Levine AJ (2000) WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. Genes Dev 14:585–595 (10.1101/gad.14.5.585) / Genes Dev by Xu (2000)
  248. Yamada T, Takaoka AS, Naishiro Y, Hayashi R, Maruyama K, Maesawa C, Ochiai A, Hirohashi S (2000) Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis. Cancer Res 60:4761–4766 / Cancer Res by Yamada (2000)
  249. Yamada Y, Oyama T, Hirose Y, Hara A, Sugie S, Yoshida K, Yoshimi N, Mori H (2003) Beta-catenin mutation is selected during malignant transformation in colon carcinogenesis. Carcinogenesis 24:91–97 (10.1093/carcin/24.1.91) / Carcinogenesis by Yamada (2003)
  250. Yamamoto H, Kishida S, Kishida M, Ikeda S, Takada S, Kikuchi A (1999) Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability. J Biol Chem 274:10681–10684 (10.1074/jbc.274.16.10681) / J Biol Chem by Yamamoto (1999)
  251. Yan D, Wiesmann M, Rohan M, Chan V, Jefferson AB, Guo L, Sakamoto D, Caothien RH, Fuller JH, Reinhard C, Garcia PD, Randazzo FM, Escobedo J, Fantl WJ, Williams LT (2001) Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta-catenin signaling is activated in human colon tumors. Proc Natl Acad Sci USA 98:14973–14978 (10.1073/pnas.261574498) / Proc Natl Acad Sci USA by Yan (2001)
  252. Yang F, Li X, Sharma M, Sasaki CY, Longo DL, Lim B, Sun Z (2002) Linking beta-catenin to androgen-signaling pathway. J Biol Chem 277:11336–11344 (10.1074/jbc.M111962200) / J Biol Chem by Yang (2002)
  253. Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL 3rd, Lee JJ, Tilghman SM, Gumbiner BM, Costantini F (1997) The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90:181–192 (10.1016/S0092-8674(00)80324-4) / Cell by Zeng (1997)
  254. Zhang T, Otevrel T, Gao Z, Ehrlich SM, Fields JZ, Boman BM (2001a) Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 61:8664–8667 / Cancer Res by Zhang (2001)
  255. Zhang X, Gaspard JP, Chung DC (2001b) Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res 61:6050–6054 / Cancer Res by Zhang (2001)
  256. Zumbrunn J, Kinoshita K, Hyman AA, Nathke IS (2001) Binding of the adenomatous polyposis coli protein to microtubules increases microtubule stability and is regulated by GSK3 beta phosphorylation. Curr Biol 11:44–49 (10.1016/S0960-9822(01)00002-1) / Curr Biol by Zumbrunn (2001)
  257. Zurawel RH, Chiappa SA, Allen C, Raffel C (1998) Sporadic medulloblastomas contain oncogenic beta-catenin mutations. Cancer Res 58:896–899 / Cancer Res by Zurawel (1998)
Dates
Type When
Created 5 years, 8 months ago (Dec. 11, 2019, 9:55 p.m.)
Deposited 2 years, 10 months ago (Oct. 8, 2022, 2:54 a.m.)
Indexed 2 months ago (June 28, 2025, 5:04 a.m.)
Issued 22 years, 5 months ago (April 1, 2003)
Published 22 years, 5 months ago (April 1, 2003)
Published Online 22 years, 4 months ago (April 18, 2003)
Published Print 22 years, 5 months ago (April 1, 2003)
Funders 0

None